- Home
- NOW vs NVS Comparison
NOW vs NVS Comparison
Compare NOW & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOW
- NVS
- Stock Information
- Founded
- NOW 2004
- NVS 1895
- Country
- NOW United States
- NVS Switzerland
- Employees
- NOW N/A
- NVS N/A
- Industry
- NOW Computer Software: Prepackaged Software
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- NOW Technology
- NVS Health Care
- Exchange
- NOW Nasdaq
- NVS Nasdaq
- Market Cap
- NOW 190.2B
- NVS 230.5B
- IPO Year
- NOW 2012
- NVS 1991
- Fundamental
- Price
- NOW $811.33
- NVS $109.10
- Analyst Decision
- NOW Buy
- NVS Hold
- Analyst Count
- NOW 29
- NVS 6
- Target Price
- NOW $1,108.32
- NVS $123.67
- AVG Volume (30 Days)
- NOW 2.0M
- NVS 2.2M
- Earning Date
- NOW 04-23-2025
- NVS 04-29-2025
- Dividend Yield
- NOW N/A
- NVS 3.00%
- EPS Growth
- NOW N/A
- NVS N/A
- EPS
- NOW 6.84
- NVS 5.87
- Revenue
- NOW $10,984,000,000.00
- NVS $51,722,000,000.00
- Revenue This Year
- NOW $19.86
- NVS $4.36
- Revenue Next Year
- NOW $19.68
- NVS $1.93
- P/E Ratio
- NOW $118.62
- NVS $18.12
- Revenue Growth
- NOW 22.44
- NVS 10.85
- 52 Week Low
- NOW $637.99
- NVS $92.35
- 52 Week High
- NOW $1,198.09
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- NOW 31.18
- NVS 50.68
- Support Level
- NOW $777.91
- NVS $108.40
- Resistance Level
- NOW $849.25
- NVS $116.91
- Average True Range (ATR)
- NOW 33.89
- NVS 1.56
- MACD
- NOW -7.82
- NVS -0.36
- Stochastic Oscillator
- NOW 19.05
- NVS 16.91
About NOW ServiceNow Inc.
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.